IMVT - Immunovant, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$43.67
DETAILS
HIGH:
$50.00
LOW:
$40.00
MEDIAN:
$41.00
CONSENSUS:
$43.67
UPSIDE:
27.88%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 9.09 |
| Quick Ratio | 9.09 |
| Solvency Ratio | -4.813 |
| Cash Ratio | 8.64 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-8.96
Peers avg: 22.9
|
| PEG Ratio | -6.12 |
| Forward PEG | -6.12 |
| Price/Book | 5.31 |
| Price/Sales | 0.00 |
| Price/FCF | -11.12 |
| Price/Op Cash Flow | -11.13 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0001 |
| Debt/Equity | 0.0001 |
| Debt/Capital | 0.0001 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.12 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -3.901 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 100.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -7398.72 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -5657.08 |
| Operating Cash Flow Coverage | -5657.08 |
| Capital Expenditure Coverage | -50913.75 |
| Dividend + Capital Expenditure Coverage | -50913.75 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -2.772 |
| Debt/Share | 0.0004 |
| Cash/Share | 4.95 |
| Book Value/Share | 4.67 |
| Tangible BV/Share | 4.67 |
| Equity/Share | 4.67 |
| Operating Cash Flow/Share | -2.233 |
| Capital Expenditure/Share | 0.000 |
| FCF/Share | -2.233 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.948 |
| Price/Fair Value | 5.31 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | -0.0% |
| Enterprise Value Multiple | -6.82 |